Though the authors conclude that both topiramate and fluvoxamine monotherapies may be effective in the treatment of PG, improvement on the PG-CGI for fluvoxamine did not quite reach statistical significance.
← all excerpts
Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives.
1
—
—